BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31526091)

  • 1. Mitochondrial CHCHD2 and CHCHD10: Roles in Neurological Diseases and Therapeutic Implications.
    Zhou W; Ma D; Tan EK
    Neuroscientist; 2020 Apr; 26(2):170-184. PubMed ID: 31526091
    [No Abstract]   [Full Text] [Related]  

  • 2. PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction.
    Zhou W; Ma D; Sun AX; Tran HD; Ma DL; Singh BK; Zhou J; Zhang J; Wang D; Zhao Y; Yen PM; Goh E; Tan EK
    Hum Mol Genet; 2019 Apr; 28(7):1100-1116. PubMed ID: 30496485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10.
    Huang X; Wu BP; Nguyen D; Liu YT; Marani M; Hench J; Bénit P; Kozjak-Pavlovic V; Rustin P; Frank S; Narendra DP
    Hum Mol Genet; 2018 Nov; 27(22):3881-3900. PubMed ID: 30084972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALS and Parkinson's disease genes CHCHD10 and CHCHD2 modify synaptic transcriptomes in human iPSC-derived motor neurons.
    Harjuhaahto S; Rasila TS; Molchanova SM; Woldegebriel R; Kvist J; Konovalova S; Sainio MT; Pennonen J; Torregrosa-Muñumer R; Ibrahim H; Otonkoski T; Taira T; Ylikallio E; Tyynismaa H
    Neurobiol Dis; 2020 Jul; 141():104940. PubMed ID: 32437855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
    Imai Y; Meng H; Shiba-Fukushima K; Hattori N
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHCHD2 and CHCHD10-related neurodegeneration: molecular pathogenesis and the path to precision therapy.
    Shammas MK; Huang TH; Narendra DP
    Biochem Soc Trans; 2023 Apr; 51(2):797-809. PubMed ID: 37021679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions.
    Burstein SR; Valsecchi F; Kawamata H; Bourens M; Zeng R; Zuberi A; Milner TA; Cloonan SM; Lutz C; Barrientos A; Manfredi G
    Hum Mol Genet; 2018 Jan; 27(1):160-177. PubMed ID: 29112723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of mitochondrial Chchd10 or Chchd2 in zebrafish leads to an ALS-like phenotype and Complex I deficiency independent of the mitochondrial integrated stress response.
    Petel Légaré V; Rampal CJ; Gurberg TJN; Aaltonen MJ; Janer A; Zinman L; Shoubridge EA; Armstrong GAB
    Dev Neurobiol; 2023 Jan; 83(1-2):54-69. PubMed ID: 36799027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of CHCHD2 and CHCHD10 in Italian patients with Parkinson's disease.
    Rubino E; Brusa L; Zhang M; Boschi S; Govone F; Vacca A; Gai A; Pinessi L; Lopiano L; Rogaeva E; Rainero I
    Neurobiol Aging; 2017 May; 53():193.e7-193.e8. PubMed ID: 28108040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61I.
    Mao C; Wang H; Luo H; Zhang S; Xu H; Zhang S; Rosenblum J; Wang Z; Zhang Q; Tang M; Shepard MJ; Wang X; Wang Y; Zhuang Z; Shi C; Xu Y
    Neurobiol Aging; 2019 Mar; 75():38-41. PubMed ID: 30530185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS.
    Straub IR; Janer A; Weraarpachai W; Zinman L; Robertson J; Rogaeva E; Shoubridge EA
    Hum Mol Genet; 2018 Jan; 27(1):178-189. PubMed ID: 29121267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHCHD2 and CHCHD10: Future therapeutic targets in cognitive disorder and motor neuron disorder.
    Jiang T; Wang Y; Wang X; Xu J
    Front Neurosci; 2022; 16():988265. PubMed ID: 36061599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHCHD2 and CHCHD10 regulate mitochondrial dynamics and integrated stress response.
    Ruan Y; Hu J; Che Y; Liu Y; Luo Z; Cheng J; Han Q; He H; Zhou Q
    Cell Death Dis; 2022 Feb; 13(2):156. PubMed ID: 35173147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis of CHCHD2 and CHCHD10 in Italian patients with mitochondrial myopathy.
    Rubino E; Zhang M; Mongini T; Boschi S; Vercelli L; Vacca A; Govone F; Gai A; Giordana MT; Grinberg M; Rogaeva E; Rainero I
    Neurobiol Aging; 2018 Jun; 66():181.e1-181.e2. PubMed ID: 29519717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases.
    Genin EC; Bannwarth S; Lespinasse F; Ortega-Vila B; Fragaki K; Itoh K; Villa E; Lacas-Gervais S; Jokela M; Auranen M; Ylikallio E; Mauri-Crouzet A; Tyynismaa H; Vihola A; Augé G; Cochaud C; Sesaki H; Ricci JE; Udd B; Vives-Bauza C; Paquis-Flucklinger V
    Neurobiol Dis; 2018 Nov; 119():159-171. PubMed ID: 30092269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of CHCHD2 and CHCHD10 activates OMA1 peptidase to disrupt mitochondrial cristae phenocopying patient mutations.
    Liu YT; Huang X; Nguyen D; Shammas MK; Wu BP; Dombi E; Springer DA; Poulton J; Sekine S; Narendra DP
    Hum Mol Genet; 2020 Jun; 29(9):1547-1567. PubMed ID: 32338760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10
    Genin EC; Madji Hounoum B; Bannwarth S; Fragaki K; Lacas-Gervais S; Mauri-Crouzet A; Lespinasse F; Neveu J; Ropert B; Augé G; Cochaud C; Lefebvre-Omar C; Bigou S; Chiot A; Mochel F; Boillée S; Lobsiger CS; Bohl D; Ricci JE; Paquis-Flucklinger V
    Acta Neuropathol; 2019 Jul; 138(1):123-145. PubMed ID: 30874923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHCHD10-regulated OPA1-mitofilin complex mediates TDP-43-induced mitochondrial phenotypes associated with frontotemporal dementia.
    Liu T; Woo JA; Bukhari MZ; LePochat P; Chacko A; Selenica MB; Yan Y; Kotsiviras P; Buosi SC; Zhao X; Kang DE
    FASEB J; 2020 Jun; 34(6):8493-8509. PubMed ID: 32369233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological characterization of a novel mouse model expressing the PD-linked CHCHD2-T61I mutation.
    Kee TR; Wehinger JL; Gonzalez PE; Nguyen E; McGill Percy KC; Khan SA; Chaput D; Wang X; Liu T; Kang DE; Woo JA
    Hum Mol Genet; 2022 Nov; 31(23):3987-4005. PubMed ID: 35786718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALS/FTD mutant CHCHD10 mice reveal a tissue-specific toxic gain-of-function and mitochondrial stress response.
    Anderson CJ; Bredvik K; Burstein SR; Davis C; Meadows SM; Dash J; Case L; Milner TA; Kawamata H; Zuberi A; Piersigilli A; Lutz C; Manfredi G
    Acta Neuropathol; 2019 Jul; 138(1):103-121. PubMed ID: 30877432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.